
Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered ... Celcuity Inc is clinical-stage biotechnology company seeking to extend the lives of cancer patients by pursuing an integrated therapeutic (Rx) and companion diagnostic (CDx) strategy. The company's drug candidate, gedatolisib, is a potent, well-tolerated, small molecule dual inhibitor, administered intravenously, that selectively targets all class I isoforms of PI3K and mammalian target of rapamycin (mTOR). 詳細を表示
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.4 | -3.97614314115 | 10.06 | 11 | 8.95 | 279900 | 10.53140868 | CS |
4 | -2.9 | -23.0891719745 | 12.56 | 13.425 | 8.53 | 293329 | 10.65469398 | CS |
12 | -2.13 | -18.0661577608 | 11.79 | 13.91 | 8.53 | 271536 | 11.6238335 | CS |
26 | -5.51 | -36.3216875412 | 15.17 | 16.5431 | 8.53 | 265185 | 13.01410516 | CS |
52 | -8.39 | -46.4819944598 | 18.05 | 22.188 | 8.53 | 289916 | 15.18205097 | CS |
156 | 0.92 | 10.5263157895 | 8.74 | 22.188 | 4.81 | 152095 | 13.85398668 | CS |
260 | 3.22 | 50 | 6.44 | 33.01 | 4.03 | 124097 | 15.77005032 | CS |
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約